Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 1,484 articles

Articles by Daniel Marsh

Merck's $6.7B Terns Buyout Anchors Stock Near Offer Price
Markets

Merck's $6.7B Terns Buyout Anchors Stock Near Offer Price

Merck has agreed to acquire Terns Pharmaceuticals in a $6.7 billion all-cash deal. Terns shares traded at $52.86, close to Merck's $53-per-share offer, as investors weigh the deal's completion.

MRK TERN ABBV BMY NVS
Clear Secure Stock Nears 52-Week Peak Amid Airport Chaos-Driven App Surge
Markets

Clear Secure Stock Nears 52-Week Peak Amid Airport Chaos-Driven App Surge

Clear Secure shares are trading near a 52-week high, buoyed by a surge in app usage as airport security wait times exceed four hours. The company reported strong Q4 revenue growth of 16.7% to $240.8 million.

YOU
Treasury Yields Surge as Mideast Tensions Fuel Inflation Fears
Markets

Treasury Yields Surge as Mideast Tensions Fuel Inflation Fears

U.S. Treasury yields rose sharply Thursday, reversing a brief rally, as renewed geopolitical uncertainty sent oil prices soaring and forced markets to reassess the Federal Reserve's interest rate path.

USO TLT XLF
Stock Futures Retreat as Iran Ceasefire Hopes Dim, Fueling Inflation Fears
Markets

Stock Futures Retreat as Iran Ceasefire Hopes Dim, Fueling Inflation Fears

U.S. stock futures declined early Thursday, reversing a prior rally as hopes for U.S.-Iran talks faded, sending oil prices higher and reigniting inflation concerns.

USO XLE
Futures Retreat as Oil Surge Dampens Rate Cut Hopes
Markets

Futures Retreat as Oil Surge Dampens Rate Cut Hopes

U.S. equity futures declined early Thursday, with the S&P 500 and Nasdaq-100 futures down 0.4%, as a rebound in oil prices above $104 a barrel soured investor mood and shifted expectations for monetary policy.

ARM AMD INTC USO
Markets React to Geopolitical Tensions, Energy Stocks in Focus
Markets

Markets React to Geopolitical Tensions, Energy Stocks in Focus

U.S. equity indices rose Wednesday amid diplomatic efforts in the Middle East, contrasting with declines in Asian markets and a spike in crude oil prices. Several individual stocks, including Kistos and Clipper Realty, moved against analyst sentiment.

USO GLD SLV XLE
Robinhood Announces $1.5 Billion Share Repurchase, Stock Jumps
Markets

Robinhood Announces $1.5 Billion Share Repurchase, Stock Jumps

Robinhood Markets has approved a new $1.5 billion stock repurchase authorization, sending its shares higher in early trading. The move comes as the company seeks to stabilize its stock price after a period of volatility.

HOOD SCHW COIN FXI
Tesla Shares Gain on European Sales Rebound Amid Lingering Delivery Concerns
Markets

Tesla Shares Gain on European Sales Rebound Amid Lingering Delivery Concerns

Tesla shares advanced roughly 2% premarket Wednesday following a rebound in European vehicle registrations, ending a 13-month slide. However, BYD maintained a narrow sales lead in the region, and investors remain focused on tempered delivery expectations and upcoming regulatory decisions.

TSLA BYD STLA FXI XLK
Airline Stocks Rally as Oil Price Dip Eases Fuel Cost Pressure
Markets

Airline Stocks Rally as Oil Price Dip Eases Fuel Cost Pressure

Airline stocks advanced Wednesday as declining oil prices alleviated fuel cost pressures. American Airlines gained 3.6%, with United and Delta also rising.

AAL UAL DAL USO
Merck Acquires Terns Pharma in $6.7B Deal to Fortify Cancer Portfolio
Markets

Merck Acquires Terns Pharma in $6.7B Deal to Fortify Cancer Portfolio

Merck will purchase Terns Pharmaceuticals for $53 per share in cash, a transaction valued at approximately $6.7 billion. The acquisition provides Merck with an experimental leukemia therapy as it prepares for the loss of exclusivity for its blockbuster drug Keytruda.

MRK NVS
SoFi Shares Slide Amid Muddy Waters Allegations, Mizuho Holds $38 Target
Markets

SoFi Shares Slide Amid Muddy Waters Allegations, Mizuho Holds $38 Target

SoFi Technologies shares declined in premarket trading following a short-seller report from Muddy Waters alleging undisclosed debt. The company has refuted the claims and Mizuho Securities reiterated its $38 price target.

SOFI AFRM SQ JPM
SCHD ETF Gains Investor Attention Following Annual Rebalance and Dividend Payout
Analysis

SCHD ETF Gains Investor Attention Following Annual Rebalance and Dividend Payout

The Schwab U.S. Dividend Equity ETF (SCHD) is drawing renewed interest following its annual portfolio rebalance and a recent dividend distribution. The fund's strategic shift and income profile are being highlighted as key attractions for investors.

SCHD CVX MRK PEP COP VZ KO TXN ABT AMGN UNH VIG XLE XLV XLK